| Gene symbol | KLRK1 | Synonyms | CD314, D12S2489E, KLR, NKG2-D, NKG2D | Type of gene | protein-coding |
| Chromosome | 12 | Map location | 12p13.2 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | killer cell lectin like receptor K1 | ||||
| GTO ID | GTC1986 |
| Trial ID | NCT03692429 |
| Disease | Colorectal Cancer |
| Altered gene | NKG2D |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CYAD-101 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | AlloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells |
| Year | 2018 |
| Country | United States |
| Company sponsor | Celyad Oncology SA |
| Other ID(s) | CYAD-N2L-101 |
| Cohort 1 | |||||||||||
|
|||||||||||